These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Influence of gender and injection site on vocal fold augmentation. Mau T; Courey MS Otolaryngol Head Neck Surg; 2008 Feb; 138(2):221-5. PubMed ID: 18241720 [TBL] [Abstract][Full Text] [Related]
6. Calcium Hydroxylapatite Pulmonary Embolism after Percutaneous Injection Laryngoplasty. Won SJ; Woo SH Yonsei Med J; 2017 Nov; 58(6):1245-1248. PubMed ID: 29047252 [TBL] [Abstract][Full Text] [Related]
7. Vocal cord medialization by transcutaneous injection of calcium hydroxylapatite. Hughes RG; Morrison M J Voice; 2005 Dec; 19(4):674-8. PubMed ID: 16301109 [TBL] [Abstract][Full Text] [Related]
8. Vocal fold augmentation with calcium hydroxylapatite (CaHA). Rosen CA; Gartner-Schmidt J; Casiano R; Anderson TD; Johnson F; Reussner L; Remacle M; Sataloff RT; Abitbol J; Shaw G; Archer S; McWhorter A Otolaryngol Head Neck Surg; 2007 Feb; 136(2):198-204. PubMed ID: 17275539 [TBL] [Abstract][Full Text] [Related]
9. Comparison of voice outcome after vocal fold augmentation with fat or calcium hydroxylapatite. Lodder WL; Dikkers FG Laryngoscope; 2015 May; 125(5):1161-5. PubMed ID: 25545723 [TBL] [Abstract][Full Text] [Related]
10. Serial computed tomographic and positron emission tomographic properties of injection material used for vocal fold augmentation. Kwon TK; Lee JE; Cha WJ; Song CM; Sung MW; Kim KH Laryngoscope; 2013 Oct; 123(10):2491-6. PubMed ID: 23897671 [TBL] [Abstract][Full Text] [Related]